Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges
- PMID: 25654320
- DOI: 10.1021/acs.bioconjchem.5b00031
Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges
Abstract
Dendrimers are three-dimensional macromolecular structures originating from a central core molecule and surrounded by successive addition of branching layers (generation). These structures exhibit a high degree of molecular uniformity, narrow molecular weight distribution, tunable size and shape characteristics, as well as multivalency. Collectively, these physicochemical characteristics together with advancements in design of biodegradable backbones have conferred many applications to dendrimers in formulation science and nanopharmaceutical developments. These have included the use of dendrimers as pro-drugs and vehicles for solubilization, encapsulation, complexation, delivery, and site-specific targeting of small-molecule drugs, biopharmaceuticals, and contrast agents. We briefly review these advances, paying particular attention to attributes that make dendrimers versatile for drug formulation as well as challenging issues surrounding the future development of dendrimer-based medicines.
Similar articles
-
Recent progress in dendrimer-based nanomedicine development.Arch Pharm Res. 2018 Jun;41(6):571-582. doi: 10.1007/s12272-018-1008-4. Epub 2018 Feb 15. Arch Pharm Res. 2018. PMID: 29450862 Review.
-
Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Chem Commun (Camb). 2011 Sep 14;47(34):9572-87. doi: 10.1039/c1cc11981h. Epub 2011 Jun 9. Chem Commun (Camb). 2011. PMID: 21655634 Review.
-
Pharmaceutical and biomedical potential of surface engineered dendrimers.Crit Rev Ther Drug Carrier Syst. 2007;24(3):257-306. doi: 10.1615/critrevtherdrugcarriersyst.v24.i3.20. Crit Rev Ther Drug Carrier Syst. 2007. PMID: 17956215 Review.
-
Dendrimers - from organic synthesis to pharmaceutical applications: an update.Pharm Dev Technol. 2015 Jan;20(1):22-40. doi: 10.3109/10837450.2013.862264. Epub 2013 Dec 4. Pharm Dev Technol. 2015. PMID: 24299011 Review.
-
Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine.Mini Rev Med Chem. 2018 Feb 14;18(5):439-457. doi: 10.2174/1389557517666170512095151. Mini Rev Med Chem. 2018. PMID: 28618985 Review.
Cited by
-
Nanometer- and angstrom-scale characteristics that modulate complement responses to nanoparticles.J Control Release. 2022 Nov;351:432-443. doi: 10.1016/j.jconrel.2022.09.039. Epub 2022 Sep 27. J Control Release. 2022. PMID: 36152807 Free PMC article.
-
Recent Advances in Preclinical Research Using PAMAM Dendrimers for Cancer Gene Therapy.Int J Mol Sci. 2021 Mar 13;22(6):2912. doi: 10.3390/ijms22062912. Int J Mol Sci. 2021. PMID: 33805602 Free PMC article. Review.
-
Recent advances in nanomedicine preparative methods and their therapeutic potential for colorectal cancer: a critical review.Front Oncol. 2023 Jun 22;13:1211603. doi: 10.3389/fonc.2023.1211603. eCollection 2023. Front Oncol. 2023. PMID: 37427139 Free PMC article. Review.
-
Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV.Mol Ther Nucleic Acids. 2025 May 20;36(3):102572. doi: 10.1016/j.omtn.2025.102572. eCollection 2025 Sep 9. Mol Ther Nucleic Acids. 2025. PMID: 40529300 Free PMC article. Review.
-
A Glimpse into Dendrimers Integration in Cancer Imaging and Theranostics.Int J Mol Sci. 2023 Mar 12;24(6):5430. doi: 10.3390/ijms24065430. Int J Mol Sci. 2023. PMID: 36982503 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources